首页 | 本学科首页   官方微博 | 高级检索  
     


Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema
Authors:Dipti Pawaskar  Michael A. Tortorici  Bruce Zuraw  Timothy Craig  Marco Cicardi  Hilary Longhurst  H. Henry Li  William R. Lumry  Inmaculada Martinez‐Saguer  Joshua Jacobs  Jonathan A. Bernstein  Marc A. Riedl  Constance H. Katelaris  Paul K. Keith  Annette Feussner  Jagdev Sidhu
Affiliation:1. CSL Behring, King of Prussia, Pennsylvania;2. Department of Medicine, University of California San Diego and San Diego VA Healthcare, La Jolla, California;3. Department of Medicine, Pediatrics and Graduate Studies, Penn State University, Hershey, Pennsylvania;4. Dipartimento di Scienze Biomediche e Cliniche “L. Sacco”, Università Degli Studi Di Milano, Milan, Italy;5. Addenbrookes Hospital, Cambridge Universities NHS Foundation Trust, Cambridge, UK;6. Institute for Asthma and Allergy, Chevy Chase, Maryland;7. AARA Research CenterAllergy and Asthma Specialists, Dallas, Texas;8. Haemophilia Centre Rhine Main (HZRM), Moerfelden‐Walldorf, Germany;9. Allergy and Asthma Clinical Research Walnut Creek, Walnut Creek, California;10. Department of Immunology/Allergy, University of Cincinnati College of Medicine and Bernstein Clinical Research Center, Cincinnati, Ohio;11. Department of Medicine, Division of Rheumatology, Allergy & Immunology, University of California San Diego, San Diego, California;12. Department of Medicine, Campbelltown Hospital, Western Sydney University, Sydney, New South Wales, Australia;13. Department of Medicine, McMaster University, Hamilton, Ontario, Canada;14. CSL Behring, Marburg, Germany;15. CSL Limited, Parkville, Melbourne, Australia
Abstract:
Keywords:angioedema  clinical immunology  prevention
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号